231 related articles for article (PubMed ID: 12438576)
1. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms.
Mauser A; Saito S; Appella E; Anderson CW; Seaman WT; Kenney S
J Virol; 2002 Dec; 76(24):12503-12. PubMed ID: 12438576
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells.
Mauser A; Holley-Guthrie E; Zanation A; Yarborough W; Kaufmann W; Klingelhutz A; Seaman WT; Kenney S
J Virol; 2002 Dec; 76(24):12543-52. PubMed ID: 12438580
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation.
Darr CD; Mauser A; Kenney S
J Virol; 2001 Jul; 75(13):6135-42. PubMed ID: 11390615
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
[TBL] [Abstract][Full Text] [Related]
5. Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription.
Sato Y; Shirata N; Kudoh A; Iwahori S; Nakayama S; Murata T; Isomura H; Nishiyama Y; Tsurumi T
Virology; 2009 May; 388(1):204-11. PubMed ID: 19375142
[TBL] [Abstract][Full Text] [Related]
6. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
Zhu Q; Wani G; Wani MA; Wani AA
Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block.
Mauser A; Holley-Guthrie E; Simpson D; Kaufmann W; Kenney S
J Virol; 2002 Oct; 76(19):10030-7. PubMed ID: 12208981
[TBL] [Abstract][Full Text] [Related]
8. Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replication.
Sato Y; Shirata N; Murata T; Nakasu S; Kudoh A; Iwahori S; Nakayama S; Chiba S; Isomura H; Kanda T; Tsurumi T
Cell Cycle; 2010 Feb; 9(4):807-14. PubMed ID: 20139729
[TBL] [Abstract][Full Text] [Related]
9. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.
Baumann M; Mischak H; Dammeier S; Kolch W; Gires O; Pich D; Zeidler R; Delecluse HJ; Hammerschmidt W
J Virol; 1998 Oct; 72(10):8105-14. PubMed ID: 9733851
[TBL] [Abstract][Full Text] [Related]
11. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
[TBL] [Abstract][Full Text] [Related]
12. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
Morrison TE; Kenney SC
Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.
Cayrol C; Flemington EK
EMBO J; 1996 Jun; 15(11):2748-59. PubMed ID: 8654372
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.
Shimada A; Kato S; Enjo K; Osada M; Ikawa Y; Kohno K; Obinata M; Kanamaru R; Ikawa S; Ishioka C
Cancer Res; 1999 Jun; 59(12):2781-6. PubMed ID: 10383130
[TBL] [Abstract][Full Text] [Related]
15. Smubp-2 represses the Epstein-Barr virus lytic switch promoter.
Zhang Q; Wang YC; Montalvo EA
Virology; 1999 Mar; 255(1):160-70. PubMed ID: 10049831
[TBL] [Abstract][Full Text] [Related]
16. The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1.
Baumann M; Gires O; Kolch W; Mischak H; Zeidler R; Pich D; Hammerschmidt W
Eur J Biochem; 2000 Jun; 267(12):3891-901. PubMed ID: 10849009
[TBL] [Abstract][Full Text] [Related]
17. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.
Zhang Q; Gutsch D; Kenney S
Mol Cell Biol; 1994 Mar; 14(3):1929-38. PubMed ID: 8114724
[TBL] [Abstract][Full Text] [Related]
18. ZNF76, a novel transcriptional repressor targeting TATA-binding protein, is modulated by sumoylation.
Zheng G; Yang YC
J Biol Chem; 2004 Oct; 279(41):42410-21. PubMed ID: 15280358
[TBL] [Abstract][Full Text] [Related]
19. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
[TBL] [Abstract][Full Text] [Related]
20. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
